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Abstract
Introduction—Post-traumatic stress disorder (PTSD) may be associated with physical inactivity, 
a modifiable lifestyle factor that contributes to risk of cardiovascular and other chronic diseases; 
however, no study has evaluated the association between PTSD onset and subsequent physical 
activity (PA) changes.
Method—Analyses were conducted between October 2014 and April 2016, using data from the 
ongoing Nurses' Health Study II (N=50,327). Trauma exposure and PTSD symptoms were 
assessed using two previously validated measures, the Brief Trauma Questionnaire and Short 
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Screening Scale for DSM-IV PTSD. Average PA (hours/week) was assessed using self-report 
measures at six time points across 20 years (1989–2009). Linear mixed models with time-updated 
PTSD assessed differences in PA trajectories by trauma/PTSD status. Among a subsample of 
women whose trauma/PTSD onset during follow-up, group differences in PA patterns before and 
after onset were assessed using linear spline models.
Results—PA decreased more steeply over time among trauma-exposed women reporting four to 
five (β= −2.5E−3, SE=1.0E−3, p=0.007) or six to seven PTSD symptoms (β= −6.7E−3, SE=1.1E−3, 
p<0.001) versus women without trauma exposure, adjusting for potential confounders. Among a 
subsample of women whose trauma/PTSD symptoms onset during follow-up, no differences in PA 
were observed prior to onset; after onset, women with six to seven PTSD symptoms had a steeper 
decline (β= −17.1E−3, SE=4.2E−3, p<0.001) in PA over time than trauma-exposed women without 
PTSD.
Conclusions—Decreases in PA associated with PTSD symptoms may be a pathway through 
which PTSD influences cardiovascular and other chronic diseases.
Introduction
Post-traumatic stress disorder (PTSD), the sentinel stress-related mental disorder, has been 
declared “a life sentence” in part based on findings that the disorder is associated with 
multiple adverse physical health outcomes, particularly cardiometabolic diseases.1–5 Though 
most PTSD research has focused on men, given initial recognition of the disorder among 
military veterans,6 lifetime PTSD prevalence among women (10.4%) is twice as high as 
among men. Further, among women, the disorder is associated with higher functional 
impairment and is more likely to be chronic.7
A number of biological and behavioral mechanisms have been proposed to explain how 
PTSD might lead to multiple adverse physical health outcomes. Though many studies have 
examined PTSD in relation to health behaviors (e.g., cigarette smoking), few have 
considered physical activity (PA). Insufficient PA is the fourth leading risk factor for 
mortality8 and a major risk factor for cardiometabolic diseases.9 Moreover, increasing levels 
of PA has demonstrated efficacy as a disease prevention strategy.10,11 Meta-analyses of 
RCTs suggest that exercise interventions bestow similar benefits to those of drug 
interventions in secondary prevention of coronary heart disease and prediabetes, and are 
more effective than drug treatment among patients with stroke.12
A variety of reasons may explain PTSD's influence on PA. Individuals with PTSD may limit 
exercise owing to a heightened concern for safety, fear of bodily arousal symptoms, 
comorbid depression, substance use, insomnia, or lower motivation, self-efficacy, or social 
support.13 Empirical findings demonstrating that PTSD does in fact influence PA could 
suggest targeted intervention for individuals with PTSD to prevent long-term adverse health 
sequelae.
In a recent comprehensive literature review, Hall et al.13 identified 15 studies considering the 
relationship between PTSD and PA, though PA was identified as a primary outcome in only 
six of these studies. These studies were limited by cross-sectional designs, male-only 
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samples, small samples (N<90), and lack of control for potential confounders such as 
depression or consideration for the effect of PTSD symptoms independent of trauma. 
Findings were mixed, with some studies reporting no association and others reporting a 
significant negative association between PTSD and PA. In a retrospective study not included 
in the review, among 50 men and women with PTSD, a reduction in PA was reported 
following PTSD onset.14 Effects of trauma exposure alone were not differentiated from 
effects of PTSD. Other work has similarly suggested that patients with affective disorders 
engage in low levels of PA15; however, recent work has called for more rigorous research on 
this relationship.16 No prospective study has examined how PTSD influences PA over time, 
or if the onset of PTSD alters PA patterns.
In the current study, longitudinal data were used to examine change in PA following onset of 
PTSD symptoms in a large sample of young and middle-aged community-dwelling women 
exposed to a variety of traumas. Because the role of trauma alone versus PTSD in 
pathophysiologic processes remains unclear, effects of PTSD symptoms were considered 
separately from effects of trauma alone. Hypotheses were:
1. Women who developed PTSD symptoms would show greater decreases in PA 
over time than women who experienced no trauma, or trauma but no symptoms.
2. Higher versus lower PTSD symptom severity would be associated with greater 
reduction in PA in a dose–response manner.
History of depression and anxiety symptoms were adjusted for, as both are commonly 
comorbid with PTSD17,18 and inversely associated with PA.19,20 Additional covariates 
possibly related to both PTSD and health behaviors (age, race/ethnicity, childhood adiposity, 
and region of residence) were selected based on prior work in this cohort2 and other research 
on PTSD and PA.21
Methods
Study Population
The Nurses' Health Study II is an ongoing cohort study of 116,430 U.S. female registered 
nurses. The cohort began in 1989 and participants—aged 24–42 years at enrollment—are 
followed up biennially. In 2008, a supplementary Trauma and PTSD Screening 
Questionnaire22 was mailed to 60,804 participants who completed a supplemental 
questionnaire on violence in 2001 and the 2007 biennial questionnaire. To maximize 
retention, supplemental surveys are only sent to those who return biennial questionnaires. 
After repeated mailings, 54,224 women returned the questionnaire (89% response rate), 
which constituted implied consent.
Analysis was limited to 50,327 of these respondents, after excluding women with missing 
information on trauma or PTSD symptoms (n=3,894),and those with fewer than two 
measures of PA (n=34) (Figure 1).Women excluded from analyses were similar to those 
included; however, a smaller proportion had ever been diagnosed with depression (19.7% vs 
24.8%). A subsample was also created of women who reported worst trauma exposure or 
PTSD symptoms occurring during study follow-up, between 1989 and 2009 (n=15,353). 
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Statistical analyses of the data were conducted between October 2014 and April 2016. This 
study was approved by the Partners Healthcare Human Research Committee.
Measures
A modified version of the reliable and valid Brief Trauma Questionnaire23,24 was used to 
assess lifetime exposure to any of 15 traumatic events (e.g., physical assault, violent death of 
a close family member) or “serious traumatic event not already covered.” If participants 
reported exposure to more than one traumatic event, they identified the event they 
considered to be their worst trauma, and reported their age at occurrence. PTSD symptoms 
were queried with respect to the worst (or only) traumatic event using the seven-item Short 
Screening Scale for DSM-IV PTSD25 (additional details on the Short Screening Scale can 
be found in Appendix A.) Onset of PTSD was established according to age reported at worst 
trauma,using a specially designed question sequence developed to improve accuracy of age 
of onset of reporting of psychiatric disorders.26 Reliability of self-reported age of onset of 
trauma and PTSD has been found to be excellent in this sample (intraclass correlation, 
0.95).27
Trauma and PTSD were coded as time varying. For each year of the study, participants were 
categorized into one of five groups with increasing severity based on the year at which their 
worst traumatic event occurred:
1. no trauma exposure;
2. trauma exposure but no PTSD symptoms;
3. trauma exposure with one to three PTSD symptoms (subclinical);
4. trauma exposure with four or five PTSD symptoms (clinical); and
5. trauma exposure with six or seven PTSD symptoms (severe).
The trauma/PTSD symptom groups were based on previous research with the Short 
Screening Scale for DSM-IV PTSD recommending scores of ≥4 and ≥6 as clinical cut offs 
for PTSD.25,28
Leisure-time PA was assessed at baseline in 1989 and again in 1991, 1997, 2001, 2005, and 
2009 with a previously validated questionnaire.29 Participants were asked about the average 
weekly time doing the following activities during the preceding year: walking or hiking 
outdoors; jogging; running; bicycling; tennis, squash, or racquet ball; lap swimming; 
calisthenics, aerobics, aerobic dance, or rowing machine; and performing other vigorous 
activities (e.g., lawn mowing). In 2001, 2005, and 2009, participants were also asked about 
time spent doing lower-intensity exercise (e.g., yoga) and weight training.
Following prior work with this sample,9 time/week was summed across all activities to 
calculate a total number of hours/week of PA. Walking was only included as an activity if 
pace was brisk, very brisk, or striding (≥3 mph), as prior work has linked brisk walking pace 
with lower cardiometabolic disease risk.30,31 PA scores were Winsorized at the 99th 
percentile (25 hours/week) to reduce the impact of extreme outliers and potentially 
erroneous reports. Given the addition of activity categories in 2001 onward, PA totals at each 
Winning et al. Page 4













assessment were standardized (mean, 0; SD=1) to be comparable across time points. 
Sensitivity analyses—first, including all walking paces (e.g., easy, normal) and non-
Winsorized PA scores, and then further adjusting for time-varying history of chronic disease 
(self-reported stroke, myocardial infarction, diabetes) and physical impairment (inability to 
walk)—did not change results substantially. These results are included in Appendix B.
In 1989, participants reported their age, race/ethnicity (categorized here as white, black, 
Asian, Hispanic, or other), and childhood adiposity. Participants selected one of nine 
pictograms of somatotype (body shape and size) at age 5 years, which was used to estimate 
childhood adiposity.32,33 Somatotypes 5–9 were collapsed into a single category 
representing the greatest adiposity (because few respondents endorsed levels >5). Region of 
residence at age 15 years was assessed in 1993 and categorized as West, Midwest, Northeast, 
South, or Puerto Rico and non-U.S. Information pertaining to childhood SES was assessed 
in 2005, with report of both parents' educational attainment at participant's birth (maximum 
of both parents: high school or less, some college, ≥4 years of college). Lifetime history of 
depression was based on participant reports of ever being diagnosed with depression by a 
doctor at or before 2009 (yes/no).Anxiety was assessed in 1993 with the eight-item anxiety 
subscale from the Crown–Crisp index34 (range, 0–14; higher score indicates more 
symptoms). A “missing” category was included for all categorical covariates. For covariates 
other than region of residence (which had approximately 18% missing data), the amount of 
missing data was <5%.
Statistical Analysis
Linear mixed models were used to estimate the association between time-updated trauma/
PTSD symptoms and 20-year PA trajectories in the full sample. Random intercept and 
random slope models allowed for individual differences in PA at baseline and in change over 
time. Time was measured as the number of years from study baseline (1989), ranging from 0 
to 20. Women with no trauma exposure served as the reference group. Trauma/PTSD status 
was time updated each year.
A linear spline regression was fitted among the subsample of women whose trauma 
exposure or onset of PTSD symptoms occurred after baseline in 1989 (i.e., during the study 
follow-up). In this subsample, PA data before and after trauma exposure or PTSD symptom 
onset were available, facilitating direct evaluation of changes in PA related to occurrence of 
trauma and PTSD symptoms. Time was measured as the number of years from trauma/
PTSD symptom onset, ranging from –19 (years prior to onset) to +19 (years after onset), 
with 0 as the inflection point of onset (which differed for each participant). Thus, there were 
38 time points. For this analysis, all women were exposed to trauma at some point between 
1989 and 2009 (i.e., there was no trauma-unexposed group). Women with trauma exposure 
but no PTSD symptoms served as the reference group.
Each analysis involved two sets of models: Model 1 adjusted for age only, and Model 2 
additionally adjusted for race/ethnicity, parental education, childhood adiposity, adolescent 
region of residence, history of depression, and anxiety. In all models, trauma/PTSD status 
was lagged by 1 year relative to when PA levels were assessed (e.g.,PTSD status in 1990 
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was linked with PA in 1991) to reduce the likelihood that PA measurements preceded (and 
might have altered) PTSD symptoms in a given year.
Results
Table 1 summarizes the demographic characteristics of participants by trauma exposure and 
PTSD symptom status at study baseline in 1989. At study inception, slightly more than half 
the sample (n=25,382) had experienced their worst traumatic event. Over follow-up, an 
additional 15,353 women reported experiencing their worst trauma. By 2008, 19.9% 
remained trauma unexposed, 46.2% had experienced trauma but no PTSD symptoms, 16.5% 
reported one to three PTSD symptoms, 10.8% reported four to five symptoms, and 6.6% 
reported six to seven symptoms.
The PA trajectories by time-varying PTSD status over the 20-year follow-up period in the 
full sample are presented in Figure 2. Relative to women without trauma, there was a 
decrease in PA z-score over time among women with trauma exposure and four to five (β= 
−2.24E−3, SE=0.89E−3; p=0.01) or six to seven PTSD symptoms (β= −5.71E−3, 
SE=1.08E−3, p<0.001), in age-adjusted linear mixed models. Additional adjustment for race, 
somatotype, parental education, region of residence, history of depression, and anxiety did 
not change the results substantially (Appendix Table 1).
Figure 3 shows PA trajectories before and after onset of trauma/PTSD symptoms among the 
subsample of women whose PTSD symptoms onset during follow-up. Prior to trauma/PTSD 
symptom onset, no significant between-group differences in PA levels were observed. That 
is, the PA trajectories among those who later developed PTSD symptoms were similar to 
those of women who were exposed to trauma but did not develop PTSD symptoms. After 
trauma/PTSD symptom onset, women with six to seven PTSD symptoms had a steeper 
decrease in PA than trauma-exposed women with no PTSD symptoms, in minimally (β= 
−16.1E−3, SE=4.0E−3, p<0.001) and fully adjusted models (Appendix Table 2).
Discussion
This study is the first to examine the longitudinal relationship between PTSD symptoms and 
PA trajectories in women exposed to a wide range of traumatic events occurring in civilian 
settings. Moreover, this is the first study to examine trends in PA both before and after onset 
of trauma or PTSD. Overall, higher PTSD symptom levels were associated with sharper 
declines in PA over time. Among women whose trauma exposure occurred during follow-up, 
an altered PA trajectory was evident for those women who further developed the highest 
number of PTSD symptoms (six to seven). Before PTSD symptom onset, PA trajectories 
were comparable to those of women who did not subsequently develop PTSD symptoms; 
however, after symptom onset, PA levels decreased at a faster rate. Associations were 
independent of depression and anxiety, and trauma exposure alone was not associated with 
changes in PA.
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Symptoms of PTSD may influence PA levels in a number of ways. For example, individuals 
with PTSD may be less likely to exercise given a heightened concern for safety, which is 
common in PTSD,35 or fear of trauma-relevant bodily arousal symptoms triggered by 
exercise, such as shortness of breath, increased heart rate, and perspiration.36 This 
possibility is supported by recent evidence that PTSD hyperarousal symptoms (as opposed 
to re-experiencing or avoidance symptoms) show a particularly robust inverse relationship 
with exercise.35–37 Additionally, PTSD symptoms may undermine motivation to engage in 
PA and make it more difficult to start and maintain an exercise program. For example, in one 
study, patients with PTSD reported lack of motivation (24% before vs 71% after PTSD 
onset) as a justification for reducing activity.14
Having PTSD also increases comorbidity with other conditions or behaviors associated with 
decreased motivation to exercise, such as fibromyalgia,38 anhedonia or depression,18 
tobacco use,39 and alcohol use.40 Sleep disruption may create another barrier to PA among 
women with PTSD symptoms. Research suggests that approximately 70%–80% of patients 
diagnosed with PTSD experience nightmares and insomnia,41 and greater sleepiness is 
negatively correlated with subsequent exercise duration.42 In addition to these behavioral 
barriers, psychosocial factors that may promote exercise, such as social support and self-
efficacy, are lower among those with PTSD symptoms. Future research should further 
identify and test potential mechanisms, in order to develop and implement effective 
interventions.
Limitations
This study has several limitations. Although date of PTSD onset was available, PTSD 
symptoms were assessed at only one time point and in relation to the worst traumatic event, 
which may have led to some misclassification of timing and severity of PTSD symptoms, 
and perhaps an underestimation of the impact of the worst event if women had already 
experienced a somewhat less traumatic event. Furthermore, recall bias could be a concern as 
trauma exposure and PTSD symptoms were assessed retrospectively, which may have 
resulted in an underestimation of lifetime PTSD prevalence.43 However, these limitations in 
assessment would likely have biased results toward the null. PA was assessed via self-report, 
which has questionable validity among people with severe mental illness44; however, among 
individuals with PTSD, correlations between self-reported PA and accelerometers are of a 
similar magnitude to those in the general population.45 Another limitation is generalizability, 
given the population of predominately white and highly educated female nurses. The women 
in this study who experienced PTSD symptoms may represent a healthy survivor sample, as 
they all had successful nursing careers; thus, it is possible results are conservative estimates 
of the true effect of PTSD on PA. Despite adjustment for several covariates, adjustment for 
psychotropic medication and substance use could be explored in future research, along with 
other potential mediators.
This study has numerous strengths, including longitudinal data, a large well-characterized 
study population, extensive data on potential confounding factors, and repeated measures of 
PA before and after the onset of PTSD symptoms. This study considered effects in a 
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community-dwelling sample of women with exposure to a range of traumas, and was able to 
disentangle potential effects of PTSD symptoms versus trauma exposure alone or 
depression/anxiety.
Conclusions
Studies have consistently shown that regular PA is associated with better long-term mental 
and physical health, and rigorous evidence of increased cardiometabolic disease risk among 
individuals with PTSD continues to amass.1–3 Findings suggest that decreasing PA after 
PTSD onset may be a pathway through which severe PTSD symptoms influence chronic 
disease risk among women. The presence of PTSD symptoms should raise clinician 
concerns about the potential development of physical health problems and prompt closer 
attention to health behaviors, which may be modifiable even in a potentially high-risk 
population. Though the size of associations in this study was small, determinants of health 
behaviors such as PA are likely multifactorial and any one variable will likely contribute 
only modestly to such outcomes. Given robust evidence of an inverse linear dose–response 
relationship between PA and cardiometabolic disease risk,46–51 even small reductions in PA 
over time may have clinically meaningful impacts on long-term health.
Despite growing recognition in the clinical community that the adverse impact of PTSD 
extends well beyond its psychiatric parameters, current clinical management of PTSD rarely 
addresses these sequelae of PTSD. As noted by Levine and colleagues,52 “Current 
management of PTSD focuses on the psychiatric parameters of this condition with little 
emphasis on addressing the comorbid cardiometabolic risk factors that impair overall long-
term health outcomes.” At present, apart from cigarette smoking, health behaviors typically 
fall outside the scope of PTSD treatment and consideration by clinicians. This study 
highlights the importance of expanding PTSD treatments to address health-promoting 
behaviors that influence morbidity and mortality. In particular, health promotion 
interventions targeting PA among women with PTSD are of great interest. In turn, increased 
PA may further reduce PTSD symptoms, creating a positive health cycle.53,54
Extensive research on tobacco use among combat veterans with PTSD has led to several 
evidence-based smoking-cessation interventions for that population. With continued 
research and replication of findings, a similar scientific basis can be established to inform 
PA interventions for broader PTSD-affected populations, including women. With better 
prevention, the potential for earlier intervention, and more-effective treatment strategies, 
patient outcomes may improve significantly.
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Appendix A – The Short Screening Scale for DSM-IV Ptsd
With respect to the worst (or only) traumatic event, Breslau's 7-item Short Screening Scale 
for DSM-IV PTSD1 was used to assess whether the participant: (1) avoided places/people/
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activities associated with the trauma; (2) lost interest in important/enjoyable activities; (3) 
felt isolated/distant from others; (4) found it hard to have love/affection for others; (5) had a 
sense of foreshortened future; (6) had sleep difficulties; or (7) became jumpy/easily startled. 
This scale has been demonstrated to have strong psychometric properties in several 
validation studies.1-4
Symptom cut-points for the current study were selected based on prior work demonstrating 
that in relation to worst trauma, a cut-point of 6 or more symptoms has the highest positive 
predictive values (87.1%) and a high negative predictive value (95%) for clinically relevant 
cases, while a score of 4 or more on this scale defines positive cases of PTSD with a 
sensitivity of 85%, specificity of 93%, positive predictive value of 68%, and negative 
predictive value of 98%.1
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Appendix B - Sensitivity Analyses
Physical Activity Trajectories by Time-Varying PTSD Status Over the 20-
Year Follow-up Period in the Full Sample
In analyses including walking at a ‘normal’ or ‘easy’ pace (<3 mph) and with exercise not 
winsorized at 25 hours/week, original results were slightly attenuated, but showed the same 
pattern. Relative to women without trauma, physical activity z-score decreased over time 
among women with trauma exposure and 4-5 (β=-1.85E-3, SE=0.91E-3; p=0.04) or 6-7 
PTSD symptoms (β=-3.44E-3, SE=1.10E-3, p<0.01), in age-adjusted linear mixed models. 
Further adjustment for covariates did not meaningfully change results. Results were also 
similar in models adjusted for chronic disease history and physical impairment (4-5 
symptoms, β=-3.0E-3, SE=0.97E-3, p<0.01; 6-7 PTSD symptoms, β=-5.26E-3, SE=1.17E-3, 
p<0.0001).
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Physical Activity Trajectories Before and After Onset of Trauma/PTSD 
Symptoms Among the Subsample of Women Whose PTSD Symptoms 
Onset During Follow-up
In analyses including walking at a “normal” or “easy” pace (<3mph) and with exercise not 
winsorized at 25 hours/week, results were similar, with slightly greater effect sizes. After 
trauma/PTSD symptom onset, women with 6-7 PTSD symptoms had a steeper decrease in 
physical activity than trauma-exposed women with no PTSD symptoms, in minimally 
(β=-21.1E-3, SE=5.7E-3, p<0.01) and fully adjusted models.
Appendix Table 1
Linear Mixed Models of Yearly Change in Physical 
Activity z-Scores by PTSD Symptoms, 1989-2009 (Full 
Sample, N=50,327)
Trauma/PTSD category
Model 1 a Model 2 b
b value (SE) p-value b value (SE) p-value
No trauma Ref Ref Ref Ref
0 PTSD sx 0.33 ×10-3 (0.54 ×10-3) 0.55 0.35 ×10-3 (0.57 ×10-3) 0.57
1-3 PTSD sx -0.36 ×10-3 (0.75 ×10-3) 0.63 -0.72 ×10-3 (0.77 ×10-3) 0.35
4-5 PTSD sx -2.24 ×10-3 (0.89 ×10-3) 0.01* -2.49 ×10-3 (0.95 ×10-3) 0.007**
6-7 PTSD sx -5.71 ×10-3 (1.08 ×10-3) <0.001*** -6.71 ×10-3 (1.13 ×10-3) <0.001***








Adjusts for age at baseline.
b
Adjusts for age, race, parental education, adiposity, region of residence, depression, and anxiety
b
PTSD, posttraumatic stress disorder
Appendix Table 2
Linear Spline Mixed Models of Yearly Change in 
Physical Activity z-Scores, 1989-2009, Before and After 
Trauma/PTSD Symptom Onset (Subsample, N=15,353)
Trauma/PTSD category
Model 1a Model 2b
b value (SE) p-value b value (SE) p-value
Before onset
 0 PTSD sx Ref Ref Ref Ref
 1-3 PTSD sx -0.04 ×10-3 (1.43 ×10-3) 0.98 0.48 ×10-3 (1.49 ×10-3) 0.75
 4-5 PTSD sx -1.71 ×10-3 (1.60 ×10-3) 0.28 -1.64 ×10-3 (1.66 ×10-3) 0.32
 6-7 PTSD sx 3.11 ×10-3 (2.04 ×10-3) 0.13 3.25 ×10-3 (2.15 ×10-3) 0.13
After onset
Winning et al. Page 10














Model 1a Model 2b
b value (SE) p-value b value (SE) p-value
 0 PTSD sx Ref Ref Ref Ref
 1-3 PTSD sx 0.16 ×10-3 (2.76 ×10-3) 0.95 0.87 ×10-3 (2.89 ×10-3) 0.76
 4-5 PTSD sx 0.42 ×10-3 (3.15 ×10-3) 0.90 1.05 ×10-3 (3.28 ×10-3) 0.75
 6-7 PTSD sx -16.14 ×10-3 (4.01 ×10-3) <0.001 -17.12 ×10-3 (4.21 ×10-3) <0.001
Note: Boldface indicates statistical significance (p<0.001).
a
Adjusts for age at baseline.
b
Adjusts for age, race, parental education, adiposity, region of residence, depression, and anxiety
b
PTSD, posttraumatic stress disorder
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Flowchart of exclusions for deriving the analytic samples.
NHS II, Nurses' Health Study II; PTSD, posttraumatic stress disorder
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Age-adjusted predicted physical activity trajectory over time by Trauma/PTSD group in the 
full sample.
PTSD, posttraumatic stress disorder
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Age-adjusted predicted physical activity trajectory over time by Trauma/PTSD group, before 
and after trauma/PTSD onset, among women reporting trauma or PTSD onset during 
following up.
Notes: Includes women with trauma/PTSD onset during follow-up, between 1989-2009 
(n=15,353). Physical activity is calculated in hours per week and standardized using Z-score. 
Predicted values of physical activity are plotted. Zero marks the year of trauma/PTSD onset.
PTSD, posttraumatic stress disorder
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